We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOK icon
176
Stoke Therapeutics
STOK
$2.11B
$965K 0.13%
+75,127
New +$1.2M
APO icon
177
Apollo Global Management
APO
$73.4B
$962K 0.13%
20,694
+9,472
+84% +$520K
BLUE
178
DELISTED
bluebird bio
BLUE
$959K 0.13%
+7,579
New +$857K
LMAT icon
179
LeMaitre Vascular
LMAT
$1.86B
$958K 0.13%
18,912
+3,590
+23% +$179K
ASTH icon
180
Astrana Health
ASTH
$1.77B
$956K 0.13%
+24,515
New +$1.12M
B
181
Barrick Mining
B
$73.2B
$954K 0.13%
61,574
+50,654
+464% +$799K
MXL icon
182
MaxLinear
MXL
$6.8B
$954K 0.13%
29,247
+13,889
+90% +$514K
NSIT icon
183
Insight Enterprises
NSIT
$4.51B
$952K 0.13%
+11,552
New +$1.03M
FCF icon
184
First Commonwealth Financial
FCF
$2.17B
$950K 0.13%
73,981
+41,409
+127% +$580K
RRR icon
185
Red Rock Resorts
RRR
$3.62B
$947K 0.13%
27,633
+19,079
+223% +$724K
PYCR
186
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$946K 0.13%
+31,987
New +$925K
EW icon
187
Edwards Lifesciences
EW
$51.7B
$940K 0.12%
11,376
-115
-1% -$11.1K
KELYA icon
188
Kelly Services Class A
KELYA
$527M
$938K 0.12%
+69,006
New +$1.25M
NFLX icon
189
Netflix
NFLX
$309B
$938K 0.12%
+39,840
New +$885K
CPS icon
190
Cooper-Standard Automotive
CPS
$558M
$934K 0.12%
160,009
+28,992
+22% +$204K
MDRX
191
DELISTED
Veradigm Inc. Common Stock
MDRX
$932K 0.12%
+61,181
New +$990K
QGEN icon
192
Qiagen
QGEN
$8.72B
$925K 0.12%
21,133
+8,324
+65% +$411K
HRMY icon
193
Harmony Biosciences
HRMY
$2.24B
$924K 0.12%
20,852
+16,045
+334% +$783K
SBSI icon
194
Southside Bancshares
SBSI
$967M
$924K 0.12%
+26,144
New +$1M
INVX
195
Innovex International
INVX
$1.97B
$924K 0.12%
47,355
+33,057
+231% +$766K
XIFR
196
XPLR Infrastructure LP
XIFR
$1.08B
$924K 0.12%
12,774
-4,902
-28% -$393K
GHL
197
DELISTED
Greenhill & Co., Inc.
GHL
$922K 0.12%
155,277
+75,744
+95% +$597K
STRO icon
198
Sutro Biopharma
STRO
$421M
$919K 0.12%
16,554
-5,258
-24% -$311K
AGYS icon
199
Agilysys
AGYS
$3.06B
$918K 0.12%
16,587
+3,020
+22% +$152K
SXC icon
200
SunCoke Energy
SXC
$797M
$915K 0.12%
157,558
+142,893
+974% +$960K

Similar funds

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.